ciclopirox has been researched along with Diabetes Mellitus in 4 studies
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the treatment of onychomycosis, compliance and drug interactions are important considerations, as diabetic patients frequently take concomitant medications." | 2.45 | Toenail onychomycosis in diabetic patients: issues and management. ( Budihardja, D; Freund, V; Mayser, P, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farr, A | 1 |
| Effendy, I | 1 |
| Frey Tirri, B | 1 |
| Hof, H | 1 |
| Mayser, P | 2 |
| Petricevic, L | 1 |
| Ruhnke, M | 1 |
| Schaller, M | 1 |
| Schaefer, APA | 1 |
| Sustr, V | 1 |
| Willinger, B | 1 |
| Mendling, W | 1 |
| Mihailidou, C | 1 |
| Chatzistamou, I | 1 |
| Papavassiliou, AG | 1 |
| Kiaris, H | 1 |
| Freund, V | 1 |
| Budihardja, D | 1 |
| Ko, SH | 1 |
| Nauta, A | 1 |
| Morrison, SD | 1 |
| Zhou, H | 1 |
| Zimmermann, A | 1 |
| Gurtner, GC | 1 |
| Ding, S | 1 |
| Longaker, MT | 1 |
2 reviews available for ciclopirox and Diabetes Mellitus
| Article | Year |
|---|---|
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovagi | 2021 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes | 2009 |
2 other studies available for ciclopirox and Diabetes Mellitus
| Article | Year |
|---|---|
Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.
Topics: Animals; Blood Glucose; Cells, Cultured; Ciclopirox; Diabetes Mellitus; Hypoglycemic Agents; Insulin | 2016 |
Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing.
Topics: Animals; Antifungal Agents; Blotting, Western; Cell Line; Ciclopirox; Diabetes Mellitus; Gene Expres | 2011 |